{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:42:15Z","timestamp":1792680135889,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012152","name":"National Postdoctoral Program for Innovative Talents","doi-asserted-by":"publisher","award":["GZB20250895"],"award-info":[{"award-number":["GZB20250895"]}],"id":[{"id":"10.13039\/501100012152","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["No. 2024-MSLH-087"],"award-info":[{"award-number":["No. 2024-MSLH-087"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017683","name":"Dalian Science and Technology Innovation Fund","doi-asserted-by":"publisher","award":["2022DF040"],"award-info":[{"award-number":["2022DF040"]}],"id":[{"id":"10.13039\/501100017683","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08767-x","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T09:46:04Z","timestamp":1787651164000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Shikonin triggers apoptosis in lung adenocarcinoma through the FHL2-FOXO1 signaling axis"],"prefix":"10.1186","volume":"24","author":[{"given":"Shiqun","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meirong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqian","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chundong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenlong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"8767_CR1","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","volume":"20","author":"A Leiter","year":"2023","unstructured":"Leiter A, Veluswamy RR, Wisnivesky JP. The global burden of lung cancer: current status and future trends. Nat Rev Clin Oncol. 2023;20:624\u201339.","journal-title":"Nat Rev Clin Oncol"},{"key":"8767_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41572-024-00551-9","volume":"10","author":"LEL Hendriks","year":"2024","unstructured":"Hendriks LEL, Remon J, Faivre-Finn C, Garassino MC, Heymach JV, Kerr KM, et al. Non-small-cell lung cancer. Nat Rev Dis Primers. 2024;10(1):71.","journal-title":"Nat Rev Dis Primers"},{"key":"8767_CR3","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/s41591-021-01450-2","volume":"27","author":"M Wang","year":"2021","unstructured":"Wang M, Herbst RS, Boshoff C. Toward personalized treatment approaches for non-small-cell lung cancer. Nat Med. 2021;27:1345\u201356.","journal-title":"Nat Med"},{"key":"8767_CR4","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.chest.2018.08.1048","volume":"154","author":"K Suresh","year":"2018","unstructured":"Suresh K, Naidoo J, Lin CT, Danoff S. Immune Checkpoint Immunotherapy for Non-Small Cell Lung Cancer: Benefits and Pulmonary Toxicities. Chest. 2018;154:1416\u201323.","journal-title":"Chest"},{"key":"8767_CR5","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1200\/JCO.21.01626","volume":"40","author":"AC Tan","year":"2022","unstructured":"Tan AC, Tan DS. W. Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations. J Clin Oncol. 2022;40:611\u201325.","journal-title":"J Clin Oncol"},{"key":"8767_CR6","doi-asserted-by":"publisher","first-page":"1177847","DOI":"10.3389\/fimmu.2023.1177847","volume":"14","author":"J Shu","year":"2023","unstructured":"Shu J, Jiang J, Zhao G. Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis. Front Immunol. 2023;14:1177847.","journal-title":"Front Immunol"},{"key":"8767_CR7","first-page":"469","volume":"31","author":"L Verset","year":"2016","unstructured":"Verset L, Feys L, Tr\u00e9pant A-L, De Wever O, Demetter P. FHL2: a scaffold protein of carcinogenesis, tumour-stroma interactions and treatment response. Histol Histopathol. 2016;31:469\u201378.","journal-title":"Histol Histopathol"},{"key":"8767_CR8","doi-asserted-by":"publisher","first-page":"33669","DOI":"10.1074\/jbc.M002519200","volume":"275","author":"V Wixler","year":"2000","unstructured":"Wixler V, Geerts D, Laplantine E, Westhoff D, Smyth N, Aumailley M, et al. The LIM-only protein DRAL\/FHL2 binds to the cytoplasmic domain of several alpha and beta integrin chains and is recruited to adhesion complexes. J Biol Chem. 2000;275(43):33669\u201378.","journal-title":"J Biol Chem"},{"key":"8767_CR9","doi-asserted-by":"publisher","first-page":"838","DOI":"10.7150\/ijbs.31371","volume":"15","author":"Z Liu","year":"2019","unstructured":"Liu Z, Han S, Wang Y, Cui C, Zhu Q, Jiang X, et al. The LIM-Only Protein FHL2 is involved in Autophagy to Regulate the Development of Skeletal Muscle Cell. Int J Biol Sci. 2019;15(4):838\u201346.","journal-title":"Int J Biol Sci"},{"key":"8767_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1359\/JBMR.050915","volume":"21","author":"C-F Lai","year":"2006","unstructured":"Lai CF, Bai S, Uthgenannt BA, Halstead LR, McLoughlin P, Schafer BW, et al. Four and half lim protein 2 (FHL2) stimulates osteoblast differentiation. J Bone Miner Res. 2006;21(1):17\u201328.","journal-title":"J Bone Min Res"},{"key":"8767_CR11","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1007\/s11010-024-05142-6","volume":"480","author":"T Jiang","year":"2025","unstructured":"Jiang T, Zeng Q, Wang J. Unlocking the secrets of Cardiac development and function: the critical role of FHL2. Mol Cell Biochem. 2025;480:2143\u201357.","journal-title":"Mol Cell Biochem"},{"key":"8767_CR12","doi-asserted-by":"publisher","first-page":"1363643","DOI":"10.3389\/fmed.2024.1363643","volume":"11","author":"X Liu","year":"2024","unstructured":"Liu X, Yang M, Li J, Liu H, Dong Y, Zheng J, et al. Identification of CFH and FHL2 as biomarkers for idiopathic pulmonary fibrosis. Front Med (Lausanne). 2024;11:1363643.","journal-title":"Front Med (Lausanne)"},{"key":"8767_CR13","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1007\/s10238-023-01076-3","volume":"23","author":"J Zhang","year":"2023","unstructured":"Zhang J, Zeng Q, She M. The roles of FHL2 in cancer. Clin Exp Med. 2023;23:3113\u201324.","journal-title":"Clin Exp Med"},{"key":"8767_CR14","doi-asserted-by":"publisher","first-page":"30861","DOI":"10.1074\/jbc.M802525200","volume":"283","author":"S Bai","year":"2008","unstructured":"Bai S, Zha J, Zhao H, Ross FP, Teitelbaum SL. Tumor necrosis factor receptor-associated factor 6 is an intranuclear transcriptional coactivator in osteoclasts. J Biol Chem. 2008;283:30861\u20137.","journal-title":"J Biol Chem"},{"key":"8767_CR15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/iep.12436","volume":"103","author":"N Li","year":"2022","unstructured":"Li N, Xu L, Zhang J, Liu Y. High level of FHL2 exacerbates the outcome of non-small cell lung cancer (NSCLC) patients and the malignant phenotype in NSCLC cells. Int J Exp Pathol. 2022;103:90\u2013101.","journal-title":"Int J Exp Pathol"},{"key":"8767_CR16","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.21037\/jtd-23-1975","volume":"16","author":"T Chen","year":"2024","unstructured":"Chen T, Chen J, Chen Q, Liang Z, Pan L, Zhao J, et al. Promotion of non-small cell lung cancer tumor growth by FHL2 via inducing angiogenesis and vascular permeability. J Thorac Dis. 2024;16(2):1424\u201337.","journal-title":"J Thorac Dis"},{"key":"8767_CR17","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/ijc.35174","volume":"156","author":"R Kanzaki","year":"2025","unstructured":"Kanzaki R, Reid S, Bolivar P, Sj\u00f6lund J, Staaf J, Larsson S, et al. FHL2 expression by cancer-associated fibroblasts promotes metastasis and angiogenesis in lung adenocarcinoma. Int J Cancer. 2025;156(2):431\u201346.","journal-title":"Int J Cancer"},{"key":"8767_CR18","doi-asserted-by":"publisher","first-page":"112116","DOI":"10.1016\/j.phytochem.2019.112116","volume":"168","author":"S Mollaei","year":"2019","unstructured":"Mollaei S, Khanehbarndaz O, Gerami-Khashal Z, Ebadi M. Molecular identification and phytochemical screening of endophytic fungi isolated from Lithospermum officinale L. roots: A new source of shikonin. Phytochemistry. 2019;168:112116.","journal-title":"Phytochemistry"},{"key":"8767_CR19","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1093\/jpp\/rgae041","volume":"76","author":"S Iranzadeh","year":"2024","unstructured":"Iranzadeh S, Dalil D, Kohansal S, Isakhani M. Shikonin in breast cancer treatment: a comprehensive review of molecular pathways and innovative strategies. J Pharm Pharmacol. 2024;76:967\u201382.","journal-title":"J Pharm Pharmacol"},{"key":"8767_CR20","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1002\/cbin.70018","volume":"49","author":"Y Wang","year":"2025","unstructured":"Wang YY, Midie X, Cheng L, Xin W, Xiaoyan Z, Weiqi S, et al. Induction of ferroptosis by shikonin in gastric cancer via the DLEU1\/mTOR\/GPX4 axis. Cell Biol Int. 2025;49:757\u201371.","journal-title":"Cell Biol Int"},{"key":"8767_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41392-022-00888-1","volume":"7","author":"Z Yu","year":"2022","unstructured":"Yu Z, Gao J, Zhang X, Peng Y, Wei W, Xu J et al. Characterization of a small-molecule inhibitor targeting NEMO\/IKK\u03b2 to suppress colorectal cancer growth. Signal Transduct Target Ther. 2022;7(1):71.","journal-title":"Signal Transduct Target Ther"},{"key":"8767_CR22","doi-asserted-by":"publisher","first-page":"153805","DOI":"10.1016\/j.phymed.2021.153805","volume":"94","author":"Q Sun","year":"2022","unstructured":"Sun Q, Gong T, Liu M, Ren S, Yang H, Zeng S, et al. A naphthalene ingredient: Therapeutic actions, pharmacokinetics, toxicology, clinical trials and pharmaceutical researches. Phytomedicine. 2022;94:153805.","journal-title":"Phytomedicine"},{"key":"8767_CR23","doi-asserted-by":"publisher","first-page":"122608","DOI":"10.1016\/j.biomaterials.2024.122608","volume":"309","author":"J Liang","year":"2024","unstructured":"Liang J, Tian X, Zhou M, Yan F, Fan J, Qin Y, et al. Shikonin and chitosan-silver nanoparticles synergize against triple-negative breast cancer through RIPK3-triggered necroptotic immunogenic cell death. Biomaterials. 2024;309:122608.","journal-title":"Biomaterials"},{"key":"8767_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.canlet.2018.03.046","volume":"425","author":"B Lu","year":"2018","unstructured":"Bin L, Zongqi W, Ye D, Xuanzhong W, Shan L, Chongcheng W, et al. RIP1 and RIP3 contribute to shikonin-induced glycolysis suppression in glioma cells via increase of intracellular hydrogen peroxide. Cancer Lett. 2018;425:31\u201342.","journal-title":"Cancer Lett"},{"key":"8767_CR25","doi-asserted-by":"publisher","first-page":"e2303835","DOI":"10.1002\/adma.202303835","volume":"35","author":"L Tang","year":"2023","unstructured":"Tang L, Yin Y, Cao Y, Fu C, Liu H, Feng J, et al. Extracellular vesicles-derived hybrid nanoplatforms for amplified CD47 blockade-based cancer immunotherapy. Adv Mater. 2023;35(35): e2303835.","journal-title":"Adv Mater"},{"key":"8767_CR26","doi-asserted-by":"crossref","unstructured":"Franken H, Mathieson T, Childs D, Sweetman GM, Werner T, T\u00f6gel I, et al. Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry. Nat Protoc. 2015;10(10):1567\u201393.","DOI":"10.1038\/nprot.2015.101"},{"key":"8767_CR27","unstructured":"Xiaolei Z, Qi W, Yanan L, Chengfei R, Shuyue W, Lianghai H, et al. Solvent-induced protein precipitation for drug target discovery on the proteomic scale. Anal. Chem. 7;92(1):1363\u201371."},{"key":"8767_CR28","doi-asserted-by":"publisher","first-page":"11564","DOI":"10.18632\/oncotarget.2595","volume":"5","author":"Y-J Cheng","year":"2014","unstructured":"Cheng YJ, Lee YC, Chiu WC, Tsai JW, Su YH, Hung AC, et al. High Id1 expression, a generally negative prognostic factor, paradoxically predicts a favorable prognosis for adjuvant paclitaxel plus cisplatin therapy in surgically treated lung cancer patients. Oncotarget. 2014;5(22):11564\u201375.","journal-title":"Oncotarget"},{"key":"8767_CR29","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.1158\/1078-0432.CCR-10-3381","volume":"17","author":"M Ponz-Sarvis\u00e9","year":"2011","unstructured":"Ponz-Sarvis\u00e9 M, Nguewa PA, Pajares MJ, et al. Inhibitor of differentiation-1 as a novel prognostic factor in NSCLC patients with adenocarcinoma histology and its potential contribution to therapy resistance. Clin Cancer Res 2011;17(12):4155\u201366.","journal-title":"Clin Cancer Res"},{"key":"8767_CR30","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.canlet.2020.01.025","volume":"475","author":"H-Y Tan","year":"2020","unstructured":"Tan HY, Wang N, Chan YT, Zhang C, Guo W, Chen F, et al. ID1 overexpression increases gefitinib sensitivity in non-small cell lung cancer by activating RIP3\/MLKL-dependent necroptosis. Cancer Lett. 2020;475:109\u201318.","journal-title":"Cancer Lett"},{"key":"8767_CR31","doi-asserted-by":"crossref","unstructured":"Xu J, Zhang Y, Li M, Shao Z, Dong Y, Li Q, et al. A single-cell characterised signature integrating heterogeneity and microenvironment of lung adenocarcinoma for prognostic stratification. EBio Med. 2024;102:105092.","DOI":"10.1016\/j.ebiom.2024.105092"},{"key":"8767_CR32","doi-asserted-by":"crossref","unstructured":"Yang Y, Hou H, Haller EM, Nicosia SV, Bai W. Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation. EMBO J. 2005;24(5):1021\u201332.","DOI":"10.1038\/sj.emboj.7600570"},{"key":"8767_CR33","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2005.08.004","volume":"2","author":"YI Kitamura","year":"2005","unstructured":"Kitamura YI, Kitamura T, Kruse JP, Raum JC, Stein R, Gu W, et al. FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. Cell Metab. 2005;2(3):153\u201363.","journal-title":"Cell Metab"},{"key":"8767_CR34","doi-asserted-by":"crossref","unstructured":"Zhang Y, Sun C, Xiao G, et al. S-nitrosylation of the peroxiredoxin-2 promotes S-nitrosoglutathione-mediated lung cancer cells apoptosis via AMPK-SIRT1 pathway. Cell Death Dis 2019;10:329.","DOI":"10.1038\/s41419-019-1561-x"},{"key":"8767_CR35","doi-asserted-by":"crossref","unstructured":"Daily JP, Minuti A, Khan N. Diagnosis, treatment, and prevention of Malaria in the US: a review. JAMA. 2022;328(5):460\u201371.","DOI":"10.1001\/jama.2022.12366"},{"key":"8767_CR36","doi-asserted-by":"crossref","unstructured":"Lu C, Zhang Z, Fan Y, Wang X, Qian J, Bian Z. Shikonin induces ferroptosis in osteosarcomas through the mitochondrial ROS-regulated HIF-1\u03b1\/HO-1 axis. Phytomedicine. 2024;135:156139.","DOI":"10.1016\/j.phymed.2024.156139"},{"key":"8767_CR37","doi-asserted-by":"crossref","unstructured":"Pan J, Li M, Yu F, Zhu F, Wang L, Ning D, et al. Up-Regulation of p53\/miR-628-3p Pathway, a Novel Mechanism of Shikonin on Inhibiting Proliferation and Inducing Apoptosis of A549 and PC-9 Non-Small Cell Lung Cancer Cell Lines. Front Pharmacol. 2021;12:766165.","DOI":"10.3389\/fphar.2021.766165"},{"key":"8767_CR38","doi-asserted-by":"crossref","unstructured":"Gao W, Wang X, Zhou Y, et al. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Sig Transduct Target Ther 2022;7:196.","DOI":"10.1038\/s41392-022-01046-3"},{"key":"8767_CR39","doi-asserted-by":"crossref","unstructured":"He X, Ma Y, Wen Y, Zhang R, Zhao D, Wang G, et al. Tumor-derived apoptotic extracellular vesicle-mediated intercellular communication promotes metastasis and stemness of lung adenocarcinoma. Bioact Mater. 2024;36:238\u201355.","DOI":"10.1016\/j.bioactmat.2024.02.026"},{"key":"8767_CR40","doi-asserted-by":"crossref","unstructured":"Rosa N, Speelman-Rooms F, Parys JB, Bultynck G. Modulation of Ca2+ signaling by antiapoptotic Bcl-2 versus Bcl-xL: From molecular mechanisms to relevance for cancer cell survival. Biochim Biophys Acta Rev Cancer. 2022;1877(6):188791.","DOI":"10.1016\/j.bbcan.2022.188791"},{"key":"8767_CR41","doi-asserted-by":"crossref","unstructured":"Eskandari E, Eaves CJ. Paradoxical roles of caspase-3 in regulating cell survival, proliferation, and tumorigenesis. J Cell Biol. 2022;221(6):e202201159.","DOI":"10.1083\/jcb.202201159"},{"key":"8767_CR42","doi-asserted-by":"crossref","unstructured":"Zieli\u0144ska Z, O\u0142dak \u0141, Gorodkiewicz E. Methods of PARP-1 Determination and its importance in living organisms. Protein Pept Lett. 2022;29(6):496\u2013504.","DOI":"10.2174\/0929866529666220405160715"},{"key":"8767_CR43","doi-asserted-by":"crossref","unstructured":"V S-B, T, A., A S-K. Apoptotic proteins with non-apoptotic activity: expression and function in cancer. Apoptosis: an international journal on programmed cell death. 2023;28.","DOI":"10.1007\/s10495-023-01835-3"},{"key":"8767_CR44","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/1759-7714.15234","volume":"15","author":"S Wang","year":"2024","unstructured":"Wang S, Liu B, Su Y, Wang N, Dong P, Xu X, et al. FHL2 promotes the aggressiveness of lung adenocarcinoma by inhibiting autophagy via activation of the PI3K\/AKT\/mTOR pathway. Thorac Cancer. 2024;15(8):630\u201341.","journal-title":"Thorac Cancer"},{"key":"8767_CR45","doi-asserted-by":"crossref","unstructured":"Johannessen M, M\u00f8ller S, Hansen T, Moens U, Van Ghelue M. The multifunctional roles of the four-and-a-half-LIM only protein FHL2. Cell Mol Life Sci. 2006;63(3):268\u201384.","DOI":"10.1007\/s00018-005-5438-z"},{"key":"8767_CR46","doi-asserted-by":"crossref","unstructured":"Cao CY, Mok SW, Cheng VW, Tsui SK. The FHL2 regulation in the transcriptional circuitry of human cancers. Gene. 2015;572(1):1\u20137.","DOI":"10.1016\/j.gene.2015.07.043"},{"key":"8767_CR47","doi-asserted-by":"crossref","unstructured":"Yang Y, Zhao Y, Liao W, Yang J, Wu L, Zheng Z, et al. Acetylation of FoxO1 activates Bim expression to induce apoptosis in response to histone deacetylase inhibitor depsipeptide treatment. Neoplasia. 2009;11(4):313\u201324.","DOI":"10.1593\/neo.81358"},{"key":"8767_CR48","doi-asserted-by":"crossref","unstructured":"Habibe JJ, Clemente-Olivo MP, Scheithauer TPM, et al. Glucose-mediated insulin secretion is improved in FHL2-deficient mice and elevated FHL2 expression in humans is associated with type 2 diabetes. Diabetologia. 2022;65(10):1721\u201333.","DOI":"10.1007\/s00125-022-05750-1"},{"key":"8767_CR49","doi-asserted-by":"crossref","unstructured":"Ebrahimnezhad M, Natami M, Bakhtiari GH, Tabnak P, Ebrahimnezhad N, Yousefi B, et al. FOXO1, a tiny protein with intricate interactions: Promising therapeutic candidate in lung cancer. Biomed Pharmacother. 2023;169:115900.","DOI":"10.1016\/j.biopha.2023.115900"},{"key":"8767_CR50","doi-asserted-by":"crossref","unstructured":"Chan JD, Scheffler CM, Munoz I, et al. FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy. Nature. 2024;629:201\u201310.","DOI":"10.1038\/s41586-024-07242-1"},{"key":"8767_CR51","doi-asserted-by":"crossref","unstructured":"Doan AE, Mueller KP, Chen AY, et al. FOXO1 is a master regulator of memory programming in CAR T cells. Nature. 2024:629:211\u201318.","DOI":"10.1038\/s41586-024-07300-8"},{"key":"8767_CR52","doi-asserted-by":"crossref","unstructured":"Cui Y, Wu X, Jin J, Man W, Li J, Li X, et al. CircHERC1 promotes non-small cell lung cancer cell progression by sequestering FOXO1 in the cytoplasm and regulating the miR-142-3p-HMGB1 axis. Mol Cancer. 2023;22(1):179.","DOI":"10.1186\/s12943-023-01888-7"},{"key":"8767_CR53","doi-asserted-by":"crossref","unstructured":"Xu S, Zou Y, Luo G, Tang L, Zhan H, Huang L, et al. Mechanistic evaluation of hyperoside against non-small cell lung cancer: a combined approach of network pharmacology and in vitro experimental validation. Discov Oncol. 2025;16(1):1757.","DOI":"10.1007\/s12672-025-03622-9"},{"key":"8767_CR54","doi-asserted-by":"crossref","unstructured":"Hu Z, Zhao P, Xu H, et al. Hyperoside exhibits anticancer activity in non\u2011small cell lung cancer cells with T790M mutations by upregulating FoxO1 via CCAT1. Oncol Rep. 2020;43:617\u201324.","DOI":"10.3892\/or.2019.7440"},{"key":"8767_CR55","doi-asserted-by":"crossref","unstructured":"Zhang X, Xiao Q, Chen H, Yang S, Li Q, Peng L. Actinidia eriantha Benth. Root as a New Phytomedicine Inhibits Non-Small Cell Lung Cancer by Regulating TGF-\u03b2\/FOXO\/mTOR. Int J Mol Sci. 2025;26(18):8957.","DOI":"10.3390\/ijms26188957"},{"key":"8767_CR56","doi-asserted-by":"crossref","unstructured":"Deng R, Tang J, Xie B, Feng G, Huang Y, Liu ZC, et al. SYUNZ\u201016, a newly synthesized alkannin derivative, induces tumor cells apoptosis and suppresses tumor growth through inhibition of PKB\/AKT kinase activity and blockade of AKT\/FOXO signal pathway. Int J Cancer 2010;127.","DOI":"10.1002\/ijc.25032"},{"key":"8767_CR57","doi-asserted-by":"crossref","unstructured":"Jeung YJ, Kim HG, Ahn J, et al. Shikonin induces apoptosis of lung cancer cells via activation of FOXO3a\/EGR1\/SIRT1 signaling antagonized by p300. Biochimica et Biophysica Acta. 2016;1863(11):2584\u201393.","DOI":"10.1016\/j.bbamcr.2016.07.005"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08767-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08767-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08767-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:12:15Z","timestamp":1792678335000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08767-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8767"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08767-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8119297\/v1","asserted-by":"object"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no conflict of interest.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1332"}}